The largest database of trusted experimental protocols

Sterile 96 well microplates

Manufactured by Greiner
Sourced in Austria

Sterile 96-well microplates are laboratory equipment used for various scientific applications. These plates provide a standardized, multi-well format for performing experiments, assays, or storage of small liquid samples. Each plate contains 96 individual wells arranged in a 8 x 12 grid, allowing for multiple samples to be processed simultaneously.

Automatically generated - may contain errors

3 protocols using sterile 96 well microplates

1

Evaluating Hemolytic Activity of RumC1-5

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hemolytic activity of RumC1-5 was evaluated as previously described.30 (link),31 (link),32 (link) Briefly, human erythrocytes (obtained from Divbioscience, NL) were pelleted by centrifugation at 800 g for 5 min. Cell pellet was then resuspended in sterile PBS and centrifuged at 800 g for 5 min. This step was repeated three times and erythrocytes were finally resuspended in Dulbecco’s modified essential medium (DMEM, Invitrogen) supplemented with 10% fetal calf serum (FCS, Invitrogen) at a concentration of 8%. One hundred μL were then added per well of sterile 96 well microplates (Greiner) containing 100 μL of DMEM +10% FCS with increasing concentrations of RumC1-5 (from 0 to 100 μM) obtained by 2-fold serial dilutions. Sterile water and Triton X-100 diluted in media at 0.1% (v/v) were used as negative and positive controls, respectively. After 1 h at 37°C, the microplates were centrifuged at 800 g for 5 min. One hundred μL of cell supernatants were collected and transferred to a new 96 well microplates and OD405 nm was measured using microplate reader (Synergy Mx, Biotek). Hemolysis caused by RumC1-5 was expressed as percentage of total hemolysis given by treatment with Triton X-100 at 0.1%. All experiments were done in triplicate.
+ Open protocol
+ Expand
2

Hemolytic Activity Evaluation of RumC1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The hemolytic activity of RumC1 was evaluated as previously described (53 (link), 56 , 57 ). Briefly, human erythrocytes (obtained from DivBioScience, NL) were pelleted by centrifugation at 800g for 5 min. Cell pellet was then resuspended in sterile PBS and centrifuged at 800g for 5 min. This step was repeated three times, and erythrocytes were lastly resuspended in PBS at a concentration of 8%. One hundred microliters were then added per well of sterile 96-well microplates (Greiner Bio-One) containing 100 μl of PBS with increasing concentrations of RumC1 (final concentrations ranging from 0 to 200 μM) obtained by twofold serial dilutions. Sterile water and Triton X-100 diluted in PBS at 0.1% (v/v) were used as negative and positive controls, respectively. After 1 hour at 37°C, the microplates were centrifuged at 800g for 5 min. One hundred microliters of cell supernatants was collected and transferred to a new 96-well microplate, and OD405nm was measured using a microplate reader (Synergy Mx, BioTek). Hemolysis caused by RumC1 was expressed as the percentage of total hemolysis given by treatment with Triton X-100 at 0.1%. All experiments were done in triplicate.
+ Open protocol
+ Expand
3

Determining MIC and MBC of HY-133 against S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Minimum inhibitory concentration (MIC) of HY-133 against S. aureus strain ATCC 29213 was determined in sterile 96-well microplates (Greiner Bio One International, Kremsmünster, Austria) following the Clinical and Laboratory Standards Institute (CLSI) guidelines, as previously described [12 (link),17 ,18 ]. Briefly, two-fold dilution series of HY-133 were prepared in cation-adjusted Mueller-Hinton broth (CAMHB, Becton Dickinson, Franklin Lakes, NJ, USA), with final concentrations ranging from 0.016–8 µg/mL. S. aureus ATCC 29213 was inoculated via direct colony suspension from stationary phase cultures grown overnight on Columbia blood agar (Becton Dickinson). A final concentration of 5 × 105 CFU/mL was used for inoculation of the 96-well microplates.
For determination of the minimum bactericidal concentration (MBC), 10 µL aliquots of culture from each microwell displaying the MIC and concentrations above were inoculated onto tryptic soy agar (TSA, Becton Dickinson) plates and incubated at 37 °C overnight. The MBC was defined as the concentration of HY-133 resulting in <500 CFU/mL (killing rate of 99.9%) [18 ]. Tests were performed in triplicate, and median values were taken for analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!